ELV

Elevance Health Inc.NYSEHealthcare

$300.74+0.75%OpenMarket Cap: $66.37B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-11	Mizuho	—	Outperform	—
2026-02-02	Truist Securities	—	Buy	—
2026-02-02	JP Morgan	—	Overweight	—
2026-01-30	Barclays	—	Overweight	—
2026-01-30	Wells Fargo	—	Overweight	—
2026-01-29	Guggenheim	—	Buy	—
2026-01-08	Wolfe Research	—	Outperform	—
2025-12-19	Deutsche Bank	—	Hold	—
2025-12-18	Morgan Stanley	—	Equal Weight	—
2025-11-26	TD Cowen	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$29.03	$197.10B	14
Sun Dec 31	$34.43	$208.24B	4
Mon Dec 31	$43.72	$219.95B	2
Tue Dec 31	$46.13	$229.50B	2

ELV | Elevance Health Inc. Analyst Ratings & Price Target - InvestLog